Developer docs
API playgroundTry for free, no card

Search company profiles

Enua

Full company profile

uuid0007v63

Namestring
Enua
Legal namestring
ENUA Pharma GmbH
Websiteurl
enua.de
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Enua Pharma GmbH is a German medical cannabis wholesale distributor headquartered in Cologne (legally registered in Aachen), founded in 2018 originally as Cannify. The company imports EU-GMP certified cannabis flowers from four named Canadian cultivators — AG Medica (Chatham, Ontario), AtlantiCann Medical Inc. (Nova Scotia), Pure Sunfarms (British Columbia), and Safari Flower (Niagara region) — and distributes them through a network of over 1,000 partner pharmacies across Germany. Enua supplements imports with proprietary strain development, expanding its portfolio from 7 to 30 in-house strains alongside a broader catalog of over 100 strains across multiple price segments.

The company's core technology is curation and quality assurance rather than software: all supplier facilities are personally vetted by Enua's quality management and product team and certified by the Cologne Bezirksregierung. Distribution is multi-channel — partner pharmacy network, direct sales/account management, a B2B e-commerce shop for pharmacies and doctors, and a telemedicine pathway integrating platforms such as Flowzz, Weed, Quick-Green, Bloomwell, and DrAnsay — supported by physician training programs and educational content marketing. Pricing for end patients starts at under €10/gram; B2B pricing is handled through the shop and direct relationships.

Enua generates revenue through unit B2B sales of medical cannabis flowers to pharmacies, with end patients reached either directly (online and brick-and-mortar pharmacy dispensing) or via telemedicine-fulfilled prescriptions. The company scaled from €20M+ revenue in 2024 (300%+ YoY growth) to €50M+ in 2025 (2.4x growth), targeting approximately €100M for 2025. Monthly sales volume grew from 250 kg in January 2024 to over 1 tonne by December 2024, and December 2024 alone generated approximately €4.3M. The company maintains double-digit EBITDA margins and in February 2026 secured €25M in debt financing from Deutsche Bank — the largest bank-backed deal in the German cannabis industry — to fund UK (Q1 2026) and Poland (end of 2026) market entry and to participate in expected German market consolidation.

Short descriptiontext

Enua Pharma GmbH is a German medical cannabis wholesale distributor that imports EU-GMP certified cannabis flowers from Canadian cultivators and distributes them to over 1,000 partner pharmacies across Germany, with planned UK and Poland expansion in 2026.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCologne, Germany
HQ citystring
Cologne
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis wholesale, pharmaceutical distribution, cannabis strain genetics, EU-GMP certified supply, pharmacy partner network
Industry2 codes
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code2 codes
  • Health and Personal Care Retailers456
  • Pharmacies and Drug Retailers456110
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Medicinal Chemicals & Botanical Products2833
Product category
Medical Cannabis Wholesale
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Cannabis Product Sales
TypeTransaction Fee
Description

Enua generates revenue through the sale of medical cannabis products (dried flower buds) to partner pharmacies across Germany. Products are sold in various price segments with over 100 strains available. The company maintains a B2B e-commerce shop for pharmacy and doctor orders.

enua.de
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Broad product portfolio across multiple price segments
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Over 100 strains available across a broad price range. Prices start at well under €10 per gram. B2B transactions handled via direct sales and B2B shop.

enua.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Enua (ENUA Pharma GmbH) is a German medical cannabis wholesale company that distributes EU-GMP certified cannabis flower products sourced from Canadian growers through a network of over 1,000 partner pharmacies in Germany. The company develops its own proprietary cannabis genetics (30 strains, up from 7) and sells to pharmacies and doctors via a B2B e-commerce shop and direct account management, with prescriptions facilitated through partner telemedicine platforms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 2.4x revenue growth in 2025 vs 2024, reaching €50M+ in sales
+2 more records
Product overview1 text field

Enua Pharma GmbH is a German medical cannabis company operating as a single-product platform with supplementary service modules. The core offering is certified medical cannabis flowers sourced from Canadian EU-GMP certified growers (AG Medica, AtlantiCann, Pure Sunfarms, Safari Flower), distributed through a B2B e-commerce platform to a network of over 1,000 partner pharmacies. The product portfolio has expanded from 7 to 30 proprietary cannabis strains, with popular varieties including Jet Fuel Gelato and Pink Kush. Supplementary offerings include a B2B shop with product certificates and educational materials, a medical cannabis brochure for pharmacists, and a newsletter service. The company is transitioning from a medical-only focus toward a broader market approach as German recreational cannabis legalization progresses.

Product and service2 records
1Medical Cannabis Flowers
CategoryMedical Cannabis Products
Description

EU-GMP certified pharmaceutical-grade cannabis flowers distributed across multiple price segments (over 100 strains total) for therapeutic prescription use in Germany. Products are sourced from EU-GMP certified Canadian growers (AG Medica, AtlantiCann, Pure Sunfarms, Safari Flower) and dispensed to patients via partner pharmacies after prescription.

2B2B E-commerce Shop
CategoryB2B Ordering Platform
Description

Dedicated online ordering platform for pharmacies and doctors to purchase medical cannabis products, with transparent product information, certificates, downloadable templates, and product details.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1AG Medica
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Canadian cannabis cultivator based in Chatham, Ontario. State-of-the-art production facility with three-story vertically integrated growing rooms. GACP and GMP certified, with focus on sustainability and water/CO2 reduction. Certified by the Cologne district government on behalf of Enua.

enua.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Canadian cultivator in Nova Scotia with purpose-built facility integrating modern technologies and strictest quality/control standards. EU-GMP and ICANN G.A.P. certified. Produces both modern craft flowers and legacy cultivars, with in-house genetics laboratory for phenotyping and breeding initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Canadian grower near Vancouver, British Columbia, operating high-tech greenhouses that continue British Columbia's tradition of high-quality cannabis cultivation. Known for Canada's most popular cannabis strains. Certified by the Cologne district government on behalf of Enua.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Canadian cannabis cultivator from the Niagara region, focusing on quality over speed. Produces craft cannabis flowers with emphasis on quality cultivation practices.

5Spital-Apotheke (Johann Matz)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Hospital pharmacy that combines centuries of pharmaceutical care with modern therapy. Works closely with Enua for stable supply chains, reliable quality, and clear processes for patient safety and continuous therapy continuity.

enua.de
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Telemedicine platforms that connect patients with doctors for cannabis prescriptions, enabling Enua's products to reach patients through partner pharmacies after telemedicine consultation.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Berlin-based medical cannabis distributor importing EU-GMP cannabis into Germany and distributing through pharmacies. Direct competitor to Enua with a similar B2B wholesale model.

TypeDirect peer
Description

German cannabis distribution platform supplying medical cannabis to pharmacies. Direct competitor to Enua in the B2B pharmacy wholesale channel.

TypeDirect peer
Description

German medical cannabis producer and distributor with domestic cultivation and pharmacy distribution. Comparable to Enua's pharmacy-channel strategy with the addition of in-house cultivation.

TypeDirect peer
Description

German medical cannabis company focused on import and pharmacy distribution. Competes directly with Enua for pharmacy shelf-space in Germany.

TypeBroad incumbent
Description

Global cannabis company supplying EU-GMP medical cannabis to German pharmacies. Competes with Enua's imported-product portfolio at much larger scale and broader geographic footprint.

TypeBroad incumbent
Description

Canadian medical cannabis producer with significant EU-GMP production and German distribution. A potential upstream supplier competitor to Enua.

TypeEmerging player
Description

Berlin-based cannabis company spanning medical and consumer segments. Overlapping with Enua in medical cannabis distribution with a broader adult-use pivot.

TypeDirect peer
Description

German medical cannabis distributor focused on pharmacy channels. Comparable B2B wholesale model targeting the same customer base as Enua.

TypeEmerging player
Description

German cannabis platform combining telemedicine, pharmacy distribution, and B2C e-commerce. Overlaps with Enua both as a distribution competitor and as a partner channel.

TypeBroad incumbent
Description

Global cannabis operator with EU-GMP production and German medical market presence. Indirect competitor at the import-source end of Enua's value chain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Enua

Medical Cannabis Wholesaleenua.de

Enua Pharma GmbH is a German medical cannabis wholesale distributor that imports EU-GMP certified cannabis flowers from Canadian cultivators and distributes them to over 1,000 partner pharmacies across Germany, with planned UK and Poland expansion in 2026.

What Enua does

Enua Pharma GmbH is a German medical cannabis wholesale distributor headquartered in Cologne (legally registered in Aachen), founded in 2018 originally as Cannify. The company imports EU-GMP certified cannabis flowers from four named Canadian cultivators — AG Medica (Chatham, Ontario), AtlantiCann Medical Inc. (Nova Scotia), Pure Sunfarms (British Columbia), and Safari Flower (Niagara region) — and distributes them through a network of over 1,000 partner pharmacies across Germany. Enua supplements imports with proprietary strain development, expanding its portfolio from 7 to 30 in-house strains alongside a broader catalog of over 100 strains across multiple price segments.

The company's core technology is curation and quality assurance rather than software: all supplier facilities are personally vetted by Enua's quality management and product team and certified by the Cologne Bezirksregierung. Distribution is multi-channel — partner pharmacy network, direct sales/account management, a B2B e-commerce shop for pharmacies and doctors, and a telemedicine pathway integrating platforms such as Flowzz, Weed, Quick-Green, Bloomwell, and DrAnsay — supported by physician training programs and educational content marketing. Pricing for end patients starts at under €10/gram; B2B pricing is handled through the shop and direct relationships.

Enua generates revenue through unit B2B sales of medical cannabis flowers to pharmacies, with end patients reached either directly (online and brick-and-mortar pharmacy dispensing) or via telemedicine-fulfilled prescriptions. The company scaled from €20M+ revenue in 2024 (300%+ YoY growth) to €50M+ in 2025 (2.4x growth), targeting approximately €100M for 2025. Monthly sales volume grew from 250 kg in January 2024 to over 1 tonne by December 2024, and December 2024 alone generated approximately €4.3M. The company maintains double-digit EBITDA margins and in February 2026 secured €25M in debt financing from Deutsche Bank — the largest bank-backed deal in the German cannabis industry — to fund UK (Q1 2026) and Poland (end of 2026) market entry and to participate in expected German market consolidation.

Enua firmographics

Firmographics
Name
Enua
Legal name
ENUA Pharma GmbH
Website
https://enua.de
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Enua Pharma GmbH is a German medical cannabis wholesale distributor that imports EU-GMP certified cannabis flowers from Canadian cultivators and distributes them to over 1,000 partner pharmacies across Germany, with planned UK and Poland expansion in 2026.
Ownership category
akta.pro rank

Enua industry classification

Industry
Product category
Medical Cannabis Wholesale
NAICS
Health and Personal Care Retailers (456), Pharmacies and Drug Retailers (456110)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Medical cannabis wholesale
  • Pharmaceutical distribution
  • Cannabis strain genetics
  • EU-GMP certified supply
  • Pharmacy partner network

Where Enua is headquartered

Location

Headquarters

HQ city
Cologne
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Enua business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Medical Cannabis Product Sales: Enua generates revenue through the sale of medical cannabis products (dried flower buds) to partner pharmacies across Germany. Products are sold in various price segments with over 100 strains available. The company maintains a B2B e-commerce shop for pharmacy and doctor orders.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goBroad product portfolio across multiple price segments

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Enua product offering

Product offering

Core offering

Enua (ENUA Pharma GmbH) is a German medical cannabis wholesale company that distributes EU-GMP certified cannabis flower products sourced from Canadian growers through a network of over 1,000 partner pharmacies in Germany. The company develops its own proprietary cannabis genetics (30 strains, up from 7) and sells to pharmacies and doctors via a B2B e-commerce shop and direct account management, with prescriptions facilitated through partner telemedicine platforms.

Product overview

Enua Pharma GmbH is a German medical cannabis company operating as a single-product platform with supplementary service modules. The core offering is certified medical cannabis flowers sourced from Canadian EU-GMP certified growers (AG Medica, AtlantiCann, Pure Sunfarms, Safari Flower), distributed through a B2B e-commerce platform to a network of over 1,000 partner pharmacies. The product portfolio has expanded from 7 to 30 proprietary cannabis strains, with popular varieties including Jet Fuel Gelato and Pink Kush. Supplementary offerings include a B2B shop with product certificates and educational materials, a medical cannabis brochure for pharmacists, and a newsletter service. The company is transitioning from a medical-only focus toward a broader market approach as German recreational cannabis legalization progresses.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Cannabis Flowers EU-GMP certified pharmaceutical-grade cannabis flowers distributed across multiple price segments (over 100 strains total) for therapeutic prescription use in Germany. Products are sourced from EU-GMP certified Canadian growers (AG Medica, AtlantiCann, Pure Sunfarms, Safari Flower) and dispensed to patients via partner pharmacies after prescription.
  • B2B E-commerce Shop Dedicated online ordering platform for pharmacies and doctors to purchase medical cannabis products, with transparent product information, certificates, downloadable templates, and product details.

Quantifiable outcome

  • 2.4x revenue growth in 2025 vs 2024, reaching €50M+ in sales
  • +2 more outcomes

Companies that use Enua

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Enua technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

Feature3 records

Enua partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • AG MedicacoreStrategic or Co-development PartnerCanadian cannabis cultivator based in Chatham, Ontario. State-of-the-art production facility with three-story vertically integrated growing rooms. GACP and GMP certified, with focus on sustainability and water/CO2 reduction. Certified by the Cologne district government on behalf of Enua.
  • AtlantiCann Medical Inc. (AMI)coreStrategic or Co-development PartnerCanadian cultivator in Nova Scotia with purpose-built facility integrating modern technologies and strictest quality/control standards. EU-GMP and ICANN G.A.P. certified. Produces both modern craft flowers and legacy cultivars, with in-house genetics laboratory for phenotyping and breeding initiatives.
  • Pure SunfarmscoreStrategic or Co-development PartnerCanadian grower near Vancouver, British Columbia, operating high-tech greenhouses that continue British Columbia's tradition of high-quality cannabis cultivation. Known for Canada's most popular cannabis strains. Certified by the Cologne district government on behalf of Enua.
  • Safari FlowercoreStrategic or Co-development PartnerCanadian cannabis cultivator from the Niagara region, focusing on quality over speed. Produces craft cannabis flowers with emphasis on quality cultivation practices.
  • Spital-Apotheke (Johann Matz)minorChannel Partner/ Reseller/ DistributorHospital pharmacy that combines centuries of pharmaceutical care with modern therapy. Works closely with Enua for stable supply chains, reliable quality, and clear processes for patient safety and continuous therapy continuity.
  • Telemedicine Platforms (Flowzz, Weed, Quick-Green, Bloomwell, DrAnsay, Cannabis Ärzte)minorChannel Partner/ Reseller/ DistributorTelemedicine platforms that connect patients with doctors for cannabis prescriptions, enabling Enua's products to reach patients through partner pharmacies after telemedicine consultation.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Enua competitors and assessment

Company assessment

Direct peers

  • Cantourage: Berlin-based medical cannabis distributor importing EU-GMP cannabis into Germany and distributing through pharmacies. Direct competitor to Enua with a similar B2B wholesale model.
  • Cansativa: German cannabis distribution platform supplying medical cannabis to pharmacies. Direct competitor to Enua in the B2B pharmacy wholesale channel.
  • Demecan: German medical cannabis producer and distributor with domestic cultivation and pharmacy distribution. Comparable to Enua's pharmacy-channel strategy with the addition of in-house cultivation.
  • Four 20 Pharma: German medical cannabis company focused on import and pharmacy distribution. Competes directly with Enua for pharmacy shelf-space in Germany.
  • Nimbus Health: German medical cannabis distributor focused on pharmacy channels. Comparable B2B wholesale model targeting the same customer base as Enua.

Broad incumbents

  • Aphria/Tilray Medical: Global cannabis company supplying EU-GMP medical cannabis to German pharmacies. Competes with Enua's imported-product portfolio at much larger scale and broader geographic footprint.
  • Aurora Cannabis: Canadian medical cannabis producer with significant EU-GMP production and German distribution. A potential upstream supplier competitor to Enua.
  • Canopy Growth: Global cannabis operator with EU-GMP production and German medical market presence. Indirect competitor at the import-source end of Enua's value chain.

Emerging players

  • Sanity Group: Berlin-based cannabis company spanning medical and consumer segments. Overlapping with Enua in medical cannabis distribution with a broader adult-use pivot.
  • Bloomwell Group: German cannabis platform combining telemedicine, pharmacy distribution, and B2C e-commerce. Overlaps with Enua both as a distribution competitor and as a partner channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Enua social profiles

Digital presence

Enua compliance and trust

Trust signal

Compliance4 records

Enua financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Enua leadership team

Management profile

Number of profiles

Profiles1 record

Enua funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Enua M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Enua

What does Enua do?

Enua (ENUA Pharma GmbH) is a German medical cannabis wholesale company that distributes EU-GMP certified cannabis flower products sourced from Canadian growers through a network of over 1,000 partner pharmacies in Germany. The company develops its own proprietary cannabis genetics (30 strains, up from 7) and sells to pharmacies and doctors via a B2B e-commerce shop and direct account management, with prescriptions facilitated through partner telemedicine platforms.

Is Enua a public or private company?

Enua is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Enua founded?

Enua was founded in 2018. It employs 51 to 100 people.

Where is Enua based?

Enua is headquartered in Cologne, Germany, in the Europe region.

How does Enua make money?

One revenue line is on record: medical Cannabis Product Sales.

Who are Enua's main competitors?

Direct peers on record are Cantourage, Cansativa, Demecan, Four 20 Pharma and Nimbus Health. Broad incumbents are Aphria/Tilray Medical, Aurora Cannabis and Canopy Growth. Emerging players are Sanity Group and Bloomwell Group.

Does Enua have an API?

No public API is recorded for Enua.

What industry is Enua in?

Enua's product category is Medical Cannabis Wholesale. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries, with a secondary code of CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services). Its NAICS code is 456 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LinkedInenua has secured €25m from Deutsche Bank 🥦 The biggest major bank-backed financing in the European cannabis industry. Today is a very special day. After long and constructive conversations…enua, a European medical cannabis company, has secured €25 million in financing from Deutsche Bank, which the company claims is the largest major bank-backed financing in the European cannabis industry. The funding will support working capital expansion, M&A activities, strategic acquisitions, and provide stability ahead of regulatory changes expected from 2026. Deutsche Bank's backing is characterized as a signal of confidence in medical cannabis standards and the industry's path toward greater legitimacy within healthcare.Startbaseenua concludes 25 million euro financing with Deutsche BankGerman medical cannabis company enua has secured €25 million in debt financing from Deutsche Bank, representing the largest financing deal in the young German cannabis industry to date, with the capital earmarked for operational growth and potential acquisitions. The company reported strong financial performance in 2025 with sales exceeding €50 million, representing 2.4x growth compared to the previous year, while maintaining a double-digit EBITDA margin. Enua is simultaneously pursuing international expansion, planning market entry into the UK in Q1 2026 and Poland by end of 2026, while positioning itself to play an active role in the expected consolidation of the German cannabis market in 2026.StartbaseStartup-News 2024 - KW 2Albert Schwarzmeier has been appointed as the new CEO and shareholder of enua Pharma GmbH, a German cannabis manufacturer. The company aims to supply 150,000 patients with cannabis and achieve an annual revenue of over 100 million EUR by 2026. Additionally, refurbed reported reaching 1 billion EUR in external sales, indicating significant growth in 2023.PR LeapLegalization debate in Germany: Cannabis expert Cannify becomes Enua Pharma GmbH / The start-up has been on the market for four years and is now one of the largest cannabis retailers in GermanyEnua Pharma GmbH, formerly known as Cannify, has rebranded to position itself for the upcoming recreational cannabis market in Germany following years of operation in the medical sector. The company aims to capture a share of the legal market by expanding its product range and securing additional debt capital through a Series A financing round planned for 2022.